Insulet
PODD
#1256
Rank
HK$140.68 B
Marketcap
HK$1,999
Share price
0.27%
Change (1 day)
-7.90%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: HK$140.68 Billion

As of February 2026 Insulet has a market cap of HK$140.68 Billion. This makes Insulet the world's 1256th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$140.68 B-11.01%
2025HK$158.08 B9.49%
2024HK$144.37 B22.01%
2023HK$118.33 B-25.92%
2022HK$159.74 B11.64%
2021HK$143.08 B9.52%
2020HK$130.64 B56.32%
2019HK$83.57 B127.34%
2018HK$36.76 B17.2%
2017HK$31.36 B86.95%
2016HK$16.77 B0.53%
2015HK$16.69 B-17.02%
2014HK$20.11 B27.42%
2013HK$15.78 B98.46%
2012HK$7.95 B14.76%
2011HK$6.93 B26.46%
2010HK$5.48 B31.12%
2009HK$4.18 B173.37%
2008HK$1.52 B-67.41%
2007HK$4.69 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Insulet was reported to be:

HK$140.59 Billion
by Nasdaq info icon info icon
HK$140.68 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.277 T 2,940.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.486 T 956.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$1.031 T 633.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$7.263 T 5,063.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
HK$10.53 B-92.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
HK$28.91 B-79.45%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$223.77 B 59.07%๐Ÿ‡บ๐Ÿ‡ธ USA